Post by Drug Development & Delivery

BioPhorum is breaking new ground with its Synthetic Molecule Process Innovation Phorum, bringing together industry giants like AstraZeneca and GSK with top regulators and CDMOs. This landmark collaboration aims to advance the rapidly evolving small molecule sector, addressing critical needs in precision oncology and next-gen therapies. Andrea Johnston highlights the urgent focus on scalable, sustainable manufacturing solutions to match scientific advancements. How will these changes impact the future of global treatments? Join the conversation and share your insights! #SyntheticMoleculeInnovation #PharmaGrowth #CDMO #RegulatoryExcellence #PrecisionMedicine